FREE Daily Stock Alerts From Stock-PR.com
Power3 Medical Products, Inc. (OTC:PWRM)
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, today announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.
In addition, Power3 is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for Power3’s depressed stock price and have distracted the company from its mission, Power3 plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, Power3 will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. Power3 intends to appeal this decision.
“We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now,” stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. “We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger.”
Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.
GreenHouse Holdings, Inc. (Pinksheets:GRHU) a leading provider of energy efficiency solutions and sustainable infrastructure products, recently announced that it has been engaged to implement Southern California Edison’s (SCE) Automated Demand Response (Auto-DR) program for three commercial/industrial customers. The customers include the PepsiCoÂ® Carson bottling facility, Sigma Plating and CRP MB Studio, LLC.
GreenHouse estimates that the projects will generate $500,000 in revenue to the company. This projection is based upon approximately 1,500 kW or 1.5 MW of electricity demand reduction and infrastructure improvements from the engagements. GreenHouse is a qualified service provider of SCE’s Auto-DR program, providing site assessment, feasibility studies, project development, engineering, and installation of enabling technologies including complete processing of all utility documents.
“Auto-DR is a rapidly growing aspect of our energy efficiency portfolio that can reap benefits for a wide range of commercial and industrial organizations, as evidenced by the diversity of these three unique customers,” said Russ Earnshaw, President of GreenHouse. “We are very pleased to be working Sigma Plating and CRP MB Studio to help them take advantage of Southern California Edison’s Auto-DR program. Management is extremely fortunate to assist another PepsiCo facility in their conservation efforts.”
GreenHouse has been engaged to implement Southern California Edison’s (SCE) Automated Demand Response (Auto-DR) program for two industrial customers. The customers include Apogee Containers, Inc. and MGE UPS, LLC. GreenHouse estimates that the projects will generate $400,000 in revenue for GreenHouse, based upon approximately 1,300 kW or 1.3 MW of electricity demand reduction and infrastructure improvements from the engagements. GreenHouse is a qualified service provider of SCE’s Auto-DR program, providing site assessment, feasibility studies, project development, engineering, and installation of enabling technologies including complete processing of all utility documents.
“Auto-DR is just one of the innovative services Greenhouse offers to help our clients implement cost effective solutions that produce positive results for all parties involved,” remarked Russ Earnshaw, President of GreenHouse. “We are truly honored to be selected by Apogee and MGE UPS and we anticipate Auto-DR being the first of many services offered in support of their energy stewardship initiatives.”
Carpenter Technology Corp. (NYSE:CRS) declared a quarterly cash dividend of $0.18 per share of common stock, payable March 3, 2011, to shareholders of record on February 1, 2011. The ex-dividend date (the date the common stock trades without the dividend) is January 28, 2011.
Carpenter Technology Corporation engages in the manufacture, fabrication, and distribution of specialty metals primarily in the United States, Europe, the Asia Pacific, Mexico, and Canada. The company operates in two segments, Advanced Metals Operations and Premium Alloys Operations.
FMC Corp. (NYSE:FMC) announced that its 2011 Annual Meeting of Stockholders will be held on Tuesday, April 26, 2011, at 2:00 p.m. ET at Top of the Tower, 1717 Arch Street, 50th Floor, Philadelphia, Pa., 19103. FMC Corporation is a diversified chemical company serving agricultural, industrial and consumer markets globally for more than a century with innovative solutions, applications and quality products.
FMC Corporation, a chemical company, provides solutions, applications, and products for agricultural, consumer, and industrial markets worldwide. It operates in three segments: Agricultural Products, Specialty Chemicals, and Industrial Chemicals.
Mead Johnson Nutrition Company (NYSE:MJN) will release its fourth quarter 2010 earnings on Thursday, Jan. 27, 2011, before the market opens. The company will host a conference call at 8:30 a.m. CST that same day during which company executives will review fourth quarter financial results and respond to questions from analysts and investors.
Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children?s nutritional products, and other nutritional products in North America, Latin America, Asia, and Europe.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM). Crown Equity Holdings Inc. (OTCPK:CRWE) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (OTCQB:GRHU). In addition to the cash, Crown Equity Holdings Inc. (OTCPK:CRWE) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
________________________________________Be Sure To Visit stock-pr.ning.com
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.